Skip to content

Analysis of susceptibility moleculde for idiopahtic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Analysis of susceptibility moleculde for idiopahtic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) - Gene expression analysis of pulmonary fibrosis and emphysema

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006692
Enrollment
100
Registered
2011-11-15
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopatic pulmonary fibrosis chronic obstructive lung disease

Interventions

None listed

Sponsors

Fukusima Medical University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In the case who recieved surgical resection of lung cancer, who have pumonary fibrosis or emphysema or normal lung

Exclusion criteria

Exclusion criteria: The cases with lung disases other than pumonary fibrosis and emphysema

Design outcomes

Primary

MeasureTime frame
Difference in gene expression between the lung tissue from the patient with pulmonary fibrosis, emphysema and without these.

Countries

Japan

Contacts

Public ContactMitsuru Munakata

Fukusima Medical University Department of Pulmonary Medicine

munakata@fmu.ac.jp024-547-1360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026